Skip to 0 minutes and 4 secondsIAN KIRKPATRICK: Welcome to week six. This week we're going to explore the crucial issue of patient involvement in the design and improvement of healthcare systems. To explore this topic, we'll focus on three issues. First of all, we'll define the term PPI, Patient and Public Involvement. We'll explore where this term comes from, what kinds of activities it is associated with, and why there is sometimes resistance to PPI from clinicians and managers. Secondly, we'll focus on some very specific initiatives in this area, often referred to as co-production or evidence based co-design. Lastly, we'll then focus on some broader issues and emerging themes associated with patient involvement.
Skip to 0 minutes and 51 secondsFor example, around the use of networks and social media to facilitate that involvement and also, whether it's possible to involve patients and consumers in the commissioning of healthcare services. To explore these themes, we will have contributions from academics such as Sophie Staniszewska from the Warwick Medical School and Rick Iedema from Monash University. We'll also hear from practitioners, such as Lynne Maher from the NHS in England. And we'll explore PPI in a number of contexts including Australia, the UK and Singapore.
Welcome to patient and public involvement in healthcare improvement
Welcome to this our final week. This week you will learn about the critical role that patients and the public, essentially the consumers of healthcare services, might play in fostering innovation and improvement.
While patient involvement is a difficult process to manage and may not be high on the agenda of policy makers or practicing clinicians, we show how it can make a critical difference.
The week starts by providing an overview of the topic of patient and public involvement, why it is important and sometimes resisted by professionals. Following this, in the second block you will learn about co-production and techniques such as Experience-based Co-design (EBCD) as recent innovations for improving healthcare services and the quality of research evidence. Lastly we explore some of the current challenges associated with patient involvement. For example, how can technology and social media be harnessed to improve patient involvement? How might meaningful patient involvement occur in health systems – such as those described in week two – where there has been a split between commissioning and service provider roles?
As in previous weeks you will hear from leading experts on this topic, including Dr Sophie Staniszewska, Warwick Medical School, Professor Rick Iedema from Monash University and Lynne Maher, previously at the NHS Institute for Innovation and Improvement.
© University of Warwick